Eltrombopag Teva

Eltrombopag Teva is a medication used to stimulate blood platelet production. It is commonly prescribed for conditions affecting platelet levels, such as chronic immune thrombocytopenia. This oral medication is manufactured by Teva Pharma S.L.U. and is available in the EU market.

Eltrombopag Teva is primarily used to increase platelet counts in individuals with chronic immune thrombocytopenia (ITP). This condition is characterized by low platelet levels, which can lead to increased bleeding and bruising. The medication works by stimulating the production of megakaryocytes, the cells responsible for producing platelets. It is also used in other conditions where low platelet counts are a concern, such as certain types of anemia or after chemotherapy.

Common effects of Eltrombopag Teva may include headaches, nausea, and fatigue. Some users may also experience diarrhea or abdominal pain. These effects are generally mild and temporary, but if they persist or worsen, it is important to consult a healthcare provider. Serious side effects are rare but can include liver problems, so regular monitoring is recommended.

Eltrombopag Teva should be handled with care, especially for individuals with liver disease or a history of liver problems. It is important to follow the prescribed dosage and administration instructions provided by a healthcare professional. Regular blood tests may be required to monitor platelet levels and liver function. Always store the medication in a cool, dry place away from direct sunlight.

Eltrombopag Teva can interact with certain medications, including those that affect liver enzymes, such as CYP1A2 inhibitors. It is important to inform your healthcare provider about all medications you are taking, including over-the-counter drugs and supplements. Alcohol consumption should be limited, as it can exacerbate the side effects of the medication. Always consult a healthcare professional before starting any new medication.